Cargando…
Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review
Six weeks of zidovudine (ZDV) is recommended for postnatal prophylaxis of HIV-exposed infants, but combination antiretrovirals are indicated if HIV transmission risk is increased. We investigated the frequency and severity of adverse events (AE) in infants receiving multiple drug prophylaxis compare...
Autores principales: | Smith, Christiana, Forster, Jeri E., Levin, Myron J., Davies, Jill, Pappas, Jennifer, Kinzie, Kay, Barr, Emily, Paul, Suzanne, McFarland, Elizabeth J., Weinberg, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441417/ https://www.ncbi.nlm.nih.gov/pubmed/26000984 http://dx.doi.org/10.1371/journal.pone.0127062 |
Ejemplares similares
-
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
por: Smith, Christiana, et al.
Publicado: (2016) -
Safety and Tolerability of Antiretrovirals during Pregnancy
por: Weinberg, Adriana, et al.
Publicado: (2011) -
Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
por: Weinberg, Adriana, et al.
Publicado: (2009) -
The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014) -
Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women
por: Weinberg, Adriana, et al.
Publicado: (2015)